Azacitidin Sandoz 25 mg/ml inj. susp. (pwdr.) s.c. vial 100 mg
Active ingredient: Azacitidine
View notice details →
News topic
All current shortage notices related to Start: 2027-04, structured by product, country, active ingredient and reporting period.
7 noticesActive ingredient: Azacitidine
View notice details →Active ingredient: Cinnarizine
View notice details →Active ingredient: Ustekinumab
View notice details →Active ingredient: Ustekinumab
View notice details →Active ingredient: Arnica montana L., Flower, Tincture, 1_20
View notice details →Active ingredient: Tiotropium
View notice details →Active ingredient: Timolol,Bimatoprost
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →